CompletedPhase 4NCT02781610
Standardized Treatment of Pulmonary Exacerbations II
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Chris Goss
- Principal Investigator
- Chris Goss, MDUniversity of Washington
- Intervention
- Standard of care IV antibiotic(s)(drug)
- Enrollment
- 982 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2020
Study locations (30)
- The Children's Hospital Alabama, Birmingham, Alabama, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- University Medical Center, Tucson, Arizona, United States
- UC San Diego Medical Center, La Jolla, California, United States
- Lucile S. Packard Children's Hospital, Palo Alto, California, United States
- University of California Davis, Health System, Sacramento, California, United States
- National Jewish Health, Denver, Colorado, United States
- Hartford Hospital, Hartford, Connecticut, United States
- Yale New Haven Hospital, New Haven, Connecticut, United States
- Shands Hospital, Gainesville, Florida, United States
- Joe DiMaggio Children's Hospital (Adult), Hollywood, Florida, United States
- University of Miami, Miami, Florida, United States
- Emory University Hospital, Atlanta, Georgia, United States
- Augusta University Medical Center, Augusta, Georgia, United States
- St. Luke's Regional Medical Center, Boise, Idaho, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Cystic Fibrosis Foundation · CF Therapeutics Development Network Coordinating Center · Medical University of South Carolina · University of Washington
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02781610 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.